Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1998
05/14/1998CA2270290A1 Therapeutic uses of bpi protein products in cystic fibrosis patients
05/14/1998CA2270171A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998CA2270137A1 Stabilized transient gene expression
05/14/1998CA2269647A1 Human squalene epoxidase
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/14/1998CA2264610A1 Branched peptide linkers
05/14/1998CA2239463A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/13/1998EP0841399A2 Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
05/13/1998EP0841396A1 Human telomerase catalytic subunit
05/13/1998EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses
05/13/1998EP0840801A2 Methods and compositions for identifying morphogen analogs
05/13/1998EP0840749A1 The h-y antigen
05/13/1998EP0840740A1 New inhibitors of platelet aggregation
05/13/1998EP0840733A1 A triazolylmethyl-indole ethylamine bisulfate salt
05/13/1998EP0840732A1 Substituted benzolactam compounds as substance p antagonists
05/13/1998EP0840731A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists
05/13/1998EP0840728A1 Heteroaryl diol acids as leukotriene antagonists
05/13/1998EP0840620A1 Il-8 antagonists for treatment of inflammatory disorders and asthma
05/13/1998EP0840608A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
05/13/1998EP0840606A1 Di- and trivalent small molecule selectin inhibitors
05/13/1998EP0840605A1 Compounds useful in the treatment of neurofibromatosis
05/13/1998EP0840601A1 Non-allosteric gaba-a agonists for treating sleep disorders
05/13/1998EP0668872B1 Calcium channel blocking polypeptides from theraphosidae aphonopelma
05/13/1998EP0660707A4 Method of preventing nmda receptor-mediated neuronal damage.
05/13/1998CN1181755A THF-containing sulfonamide inhibitors of aspartyl protease
05/13/1998CN1181753A Novel substituted piperazine derivatives having tachyknin receptor antagonists activity
05/13/1998CN1181706A Arteriovenous and venous graft treatments: methods and compsns.
05/13/1998CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/13/1998CN1038304C Method for prepn. of growth inhibiting compsn.
05/12/1998US5750720 Alpha-adrenoreceptors and central nervous systems
05/12/1998US5750712 Diabetic therapy
05/12/1998US5750706 Azepanes and their ring homologues having protein kinase inhibiting activity
05/12/1998US5750688 Reacting an halogenated amine with an oxybenzoic ester; then a 2-(oxyphenyl-)benzothiophene compound
05/12/1998US5750687 Angiotensin converting enzyme inhibitors, neutral endopeptidase inhibitors
05/12/1998US5750576 Triphenylethylenes for the prevention and treatment of osteoporosis
05/12/1998US5750573 Guanylhydrazones and their use to treat inflammatory conditions
05/12/1998US5750571 Methods and therapeutic compositions for treating cystic fibrosis
05/12/1998US5750567 Farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same
05/12/1998US5750564 Anti-oxidant esters of non-steroidal anti-inflammatory agents
05/12/1998US5750559 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
05/12/1998US5750554 Compounds for treatment of anxiety, depression, antisecretory agents, hypotensive agents and treatment of eating problems
05/12/1998US5750552 Antiulcer agents
05/12/1998US5750551 Angiotensin inhibitors, benzimidazole derivatives
05/12/1998US5750546 2-(2, 3, 5, 6-tetrafluoro-4-pyridyl)-1, 2, 5-thiadiazolidin-3-one 1, 1-dioxides and compositions and method of use thereof
05/12/1998US5750543 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/12/1998US5750539 Antiasthmatics
05/12/1998US5750531 Pyrimidine derivatives and processes for the preparation thereof
05/12/1998US5750530 Pharmaceutical diketopiperazine compounds
05/12/1998US5750524 Administering an sulfamide substituted indan derivative
05/12/1998US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE
05/12/1998US5750518 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation and rheumatoid arthritis
05/12/1998US5750514 Method for controlling ectoparasites
05/12/1998US5750495 Administering tumor necrosis factor
05/12/1998US5750493 Alpha-1-acid glycoprotein binders
05/12/1998US5750391 Filariid nematode cysteine protease proteins
05/12/1998US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus
05/12/1998US5750377 Process for preparing mammalian T cell growth factor P40
05/12/1998US5750369 DNA encoding a prostaglandin F28 receptor, a host cell transformed therewith and an expression product thereof
05/12/1998US5750351 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
05/12/1998US5750132 Adinistering extracellular, recombinant hemoglobin to treat disorders resulting from radiation, anemia, tissue ischemia
05/12/1998US5750091 Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
05/12/1998CA2030718C Tricyclic compounds
05/07/1998WO1998018926A1 Circularly permuted erythropoietin receptor agonists
05/07/1998WO1998018917A2 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE)
05/07/1998WO1998018916A1 Human p2x purinoreceptor
05/07/1998WO1998018816A1 Peptide compositions with growth factor-like activity
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018798A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
05/07/1998WO1998018788A1 Piperazino derivatives as neurokinin antagonists
05/07/1998WO1998018786A1 Constrained somatostatin agonists and antagonists
05/07/1998WO1998018785A1 Substituted oximes derivatives useful as neurokinin antagonists
05/07/1998WO1998018782A1 2-pyrimidineamine derivatives and processes for their preparation
05/07/1998WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
05/07/1998WO1998018769A1 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake
05/07/1998WO1998018761A1 Substituted arylalkylamines as neurokinin antagonists
05/07/1998WO1998018758A1 Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof
05/07/1998WO1998018484A1 Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018479A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract
05/07/1998WO1998018478A1 Tortoise oil, turtle oil, compositions containing them, their preparation processes and uses
05/07/1998WO1998018477A2 Pharmaceutical compositions containing lamivudine and zidovudine
05/07/1998WO1998018475A1 Methods of treating or preventing cardiac arrhythmia
05/07/1998WO1998018464A1 Substituted tricyclics
05/07/1998WO1998018461A1 Integrin antagonists
05/07/1998WO1998018460A1 Integrin antagonists
05/07/1998WO1998018449A1 Methods of preventing breast cancer
05/07/1998WO1998018440A2 Use of inhibitors of the activity of retinoic acid for treating sensitive skin
05/07/1998WO1998018430A2 P2y receptor antagonists
05/07/1998WO1998018429A2 A method for lowering plasma levels of lipoprotein(a)
05/07/1998WO1998018325A1 Prophylaxis of breast cancer
05/07/1998WO1998011243A3 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
05/07/1998WO1998009618A3 Graft survival prolongation with porphyrins
05/07/1998WO1998007855A3 Secreted proteins and polynucleotides encoding them
05/07/1998WO1998006747A3 Uses for wnt polypeptides
05/07/1998WO1998000173A3 Targeted drug delivery using sulfonamide derivatives
05/07/1998WO1997046683A3 Polynucleotides encoding secreted proteins
05/07/1998CA2270345A1 Immunostimulatory nucleic acid molecules
05/07/1998CA2270174A1 Pharmaceutical compositions containing lamivudine and zidovudine
05/07/1998CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269670A1 A method for lowering plasma levels of lipoprotein(a)
1 ... 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 ... 1564